Telemedicine Market Size & Share 2026-2035

Report ID: GMI3129
   |
Published Date: October 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform

Download Free PDF

Explore our licensing options:

Telemedicine Market Size

The global telemedicine market was valued at USD 129.4 billion in 2025, is projected to reach USD 145.1 billion in 2026, is forecast to grow at 11% CAGR (2026–2035), and is expected to reach USD 368.2 billion by 2035. The telemedicine market covers remote clinical care, patient monitoring, health education, and administrative services delivered through telecommunications technologies across hardware, software, and managed-service models.

Demand is shifting from episodic virtual visits toward integrated care pathways that connect consultation, monitoring, clinical documentation, and follow-up. Reimbursement permanence, provider capacity constraints, and chronic-care management needs are increasing the strategic value of platforms that can fit established clinical workflows rather than operate as standalone digital channels.

GMI Analyst View

Based on our three-method market triangulation, drawing on demand-side provider and payer data, reference-market scaling, and company revenue aggregation, we estimate that the global telemedicine market reached USD 116.00 billion in 2024. This historic anchor indicates that the sector entered the current forecast horizon with meaningful commercial scale across provider, payer, and patient-funded care models.

Telemedicine Market Trends, Growth Drivers & GMI Forecast Outlook

The telemedicine market is being shaped by the convergence of chronic-care demand, broader digital access, and clinical software modernization. Growth depends on whether platforms can translate these tailwinds into durable provider and payer adoption while managing security, interoperability, and jurisdiction-specific compliance requirements.

Key Drivers

Driver Evidence signal Market-demand implication GMI forecast condition
Chronic disease burden expanding RPM and specialty telehealth demand 589 million adults aged 20–79 were living with diabetes globally in 2024 [1] Growing chronic disease populations in endocrinology, cardiology, and pulmonary specialties increase demand for RPM devices, tele-monitoring software subscriptions, and specialist consultation services. Remote patient monitoring and chronic-care telehealth sustain above-market expansion through 2035, supporting tele-monitoring and specialty-platform demand.
Global internet connectivity enabling scalable telehealth deployment 6 billion people were online globally in 2025 [2] Expanding smartphone and mobile-broadband access broadens the addressable population for direct-to-consumer and payer-sponsored telehealth programs, especially in Asia Pacific and Latin America. Platform volumes accelerate as connectivity reaches usable thresholds in mid-income markets, strengthening regional demand growth.
AI and large language model integration in clinical telehealth workflows FDA-cleared AI diagnostic-support tools are being integrated into tele-triage, symptom screening, and clinical decision-support workflows. AI capabilities can widen the clinical scope of remotely delivered services, reduce time per consultation, and extend virtual care into specialist workflows. Cloud-based software captures AI monetization through premium subscriptions and integrated clinical-support modules.

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Chronic disease management favors care models that can maintain contact between scheduled appointments, identify deterioration earlier, and coordinate specialist intervention without requiring repeated travel. This creates a stronger commercial case for connected monitoring and care-management services than for isolated video-visit offerings, particularly where provider capacity is constrained.

Connectivity expansion also changes the economics of market entry. Platforms that support local languages, low-bandwidth workflows, and integration with public-health infrastructure are better positioned to convert access gains into sustained utilization rather than one-time digital enrollment.

Policy clarity is a further demand enabler. CMS has established a permanent-only pathway for additions to the Medicare telehealth services list beginning in CY 2026 and has retained broad beneficiary flexibility through December 31, 2027 [4]. That visibility supports longer-horizon technology, staffing, and contracting decisions by health systems and payers.

Key Restraints

Restraint Evidence signal Market-demand implication GMI forecast condition
Healthcare cybersecurity vulnerabilities imposing compliance and technology-investment burden Healthcare data breaches averaged USD 7.42 million per breach in 2025 [3] Breach exposure raises the cost of security architecture, compliance operations, and patient-trust protection for telehealth platforms. Cyber-insurance, breach-response, and security-investment requirements constrain mid-market profitability as connected devices and cloud integrations expand the attack surface.
Digital divide and broadband affordability gap constraining low-income market expansion 2.2 billion people remained offline globally in 2025 [2] Limited access to reliable connectivity restricts participation in real-time video and RPM-enabled care, narrowing the immediate addressable population in underserved communities. Penetration in MEA and rural APAC remains dependent on infrastructure buildout and affordability improvements, with adoption accelerating only as those conditions improve.
Regulatory and licensure fragmentation across jurisdictions HIPAA, GDPR, and PDPA requirements, alongside divergent clinical-licensure frameworks, require jurisdiction-specific compliance architecture. International platforms must maintain distinct clinical-registration, data-residency, and reimbursement configurations, increasing time-to-market and operating complexity. Consolidation favors providers with the capital and operational depth to absorb multi-jurisdictional compliance demands.

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Cybersecurity is not a one-time adoption hurdle because exposure increases as a platform accumulates longitudinal patient records, connected-device streams, and interfaces with clinical systems. Security capability is therefore becoming a procurement criterion alongside clinical functionality, especially for enterprise customers seeking durable virtual-care infrastructure.

The digital divide operates through both coverage and affordability. Where connectivity is absent or economically inaccessible, telemedicine providers must often rely on government, payer, or community partnerships rather than conventional consumer-acquisition models. Regulatory fragmentation compounds that challenge by limiting the portability of operating models across borders.

GMI Analyst View

We see security and regulatory readiness becoming a more durable source of differentiation than feature breadth alone. Platforms that make governance, clinical accountability, and interoperable deployment part of their operating model should be better placed to win multi-year enterprise relationships than competitors built around lower-friction consumer engagement.

Telemedicine Market Segment Analysis

By Component

The telemedicine market's component mix is moving toward recurring software and service revenue as providers seek integrated workflows instead of disconnected devices or one-off video tools.

Hardware generated USD 23.29 billion in 2025 and is projected to grow at 8.9% CAGR (2026–2035). Medical-grade monitoring devices, diagnostic kiosks, connected wearables, and sensor systems remain essential to remote patient monitoring, but growing scale in device manufacturing is placing pressure on average selling prices and shifting value capture toward recurring clinical-service layers.

Global Telemedicine Market Size, by Component, 2025 & 2035 (USD Million)

Software is expected to reach USD 147.28 billion by 2035 and accounted for 35.0% of the market in 2025. Healthcare organizations are increasingly prioritizing platforms that combine scheduling, consultation, EHR connectivity, clinical documentation, and decision support, making software architecture central to vendor selection and retention.

Cloud-based Software generated USD 32.35 billion in 2025 and is forecast to expand at 14.5% CAGR (2026–2035). Its advantage lies in continuous updates, scalable deployment, and faster integration of AI-enabled tools, although data-residency requirements and institutional risk policies preserve a role for alternative deployment models.

Services generated USD 60.82 billion in 2025 and are forecast to grow at 10.5% CAGR (2026–2035). Revenue is supported by the operationalization of telehealth across consultation, monitoring, care coordination, and provider support, rather than solely by appointment volume.

Tele-consultation generated USD 36.23 billion in 2025 and is projected to grow at 9.8% CAGR (2026–2035). The service remains the broadest entry point for virtual care, but its commercial outlook increasingly depends on integration with referral, documentation, and follow-up pathways that strengthen clinical continuity.

Tele-monitoring generated USD 15.53 billion in 2025 and is projected to grow at 13.2% CAGR (2026–2035). Chronic disease pathways, connected biometric devices, and payer interest in avoidable-utilization reduction make monitoring a strategically important route to recurring engagement and measurable care-management value.

On-premises Software continues to serve organizations with stringent data-sovereignty, government, defense, or internal-control requirements. Its role is increasingly defined by deployment assurance and integration priorities rather than by broad-based platform expansion.

Tele-education & Training supports clinician onboarding, continuing education, and specialist knowledge transfer, particularly where dispersed workforces and constrained access to expertise make remote learning operationally valuable.

By Specialty

Psychiatry generated USD 25.88 billion in 2025 and is expected to account for 19.0% of the market by 2035. The specialty is well suited to video-enabled care because assessment and treatment often rely on conversation, observation, medication management, and continuity of therapeutic relationships rather than physical examination.

Cardiology is expected to reach USD 58.91 billion by 2035 and represented 15.0% of the market in 2025. Remote rhythm monitoring, post-acute follow-up, and longitudinal management of cardiovascular conditions are expanding telemedicine from a consultation tool into a coordinated care-management channel.

Pulmonary generated USD 15.53 billion in 2025 and is forecast to grow at 10.2% CAGR (2026–2035). Home-based monitoring and chronic respiratory-care pathways create a practical setting for telemedicine, particularly when care teams need to identify deterioration between in-person visits.

Endocrinology represented 11.0% of the market in 2025 and is projected to grow at 13.8% CAGR (2026–2035). The clinical fit between continuous glucose data, medication adjustment, and specialist follow-up supports adoption, while remote access can extend scarce endocrinology capacity beyond major urban centers.

Oncology generated USD 12.94 billion in 2025 and is projected to grow at 13.4% CAGR (2026–2035). Virtual care is increasingly used to support symptom monitoring, treatment adherence, care coordination, palliative discussions, and specialist access around episodes of high-intensity care.

Gynecology generated USD 11.65 billion in 2025 and is expected to reach USD 33.14 billion by 2035. Maternal-health follow-up, reproductive-health consultations, and screening pathways are supporting platform demand, particularly where patients face geographic or scheduling barriers to in-person care.

Gastroenterology benefits from telemedicine in medication management, dietary support, and follow-up care, although diagnostic workflows that require procedures or physical assessment limit full virtualization.

Rheumatology uses virtual channels for longitudinal monitoring, medication review, and patient education, while diagnostic and disease-assessment requirements preserve the importance of in-person clinical touchpoints.

By End Use

Healthcare Providers generated USD 71.17 billion in 2025 and are forecast to grow at 10.4% CAGR (2026–2035). Hospitals, physician groups, and specialty clinics are embedding telemedicine in capacity-management strategies, using it to extend specialist reach, support hospital-at-home programs, and improve continuity after discharge.

Global Telemedicine Market Share, by End Use, 2025

Hospitals & Clinics generated USD 49.17 billion in 2025 and are expected to reach USD 128.87 billion by 2035. Their spending priorities favor platforms that can integrate with clinical systems, accommodate governance requirements, and support operational workflows across multiple departments.

Long-term Care facilities are increasingly using telemedicine and monitoring tools to manage complex chronic populations where on-site physician availability is limited. The model is particularly relevant where early escalation and specialist access can reduce unnecessary transfers.

Payers are expected to reach USD 84.69 billion by 2035 and represented 22.0% of the market in 2025. For health plans, the strategic value of telemedicine lies in directing members toward appropriate care settings, supporting chronic-condition engagement, and incorporating virtual care into broader value-based benefit design.

Patients generated USD 19.41 billion in 2025 and are forecast to grow at 14.7% CAGR (2026–2035). Consumer demand is strongest where convenience, behavioral-health access, chronic-condition support, and transparent digital experiences reduce the friction of seeking care.

GMI Analyst View

We believe the important competitive shift is from selling access to selling clinical operating capability. Vendors that can combine specialty workflows, AI-supported triage, and reliable longitudinal engagement are better positioned to defend recurring revenue than those whose value proposition remains centered on virtual appointment availability.

Telemedicine Market Regional Analysis

Global Telemedicine Market Share, by Region, 2025 & 2035

North America Telemedicine Market Analysis

The telemedicine market in North America generated USD 50.47 billion in 2025 and is expected to reach USD 125.19 billion by 2035. Mature reimbursement structures, high enterprise technology adoption, and demand for behavioral health, chronic-care management, and hospital-at-home services provide a strong foundation for integrated virtual-care deployment.

U.S.

The U.S. remains the region's principal commercial market, supported by employer-sponsored benefits, provider-network investment, and expanding integration of virtual care into payer and health-system models. Federal policy clarity is improving the investment case for platforms that require long-term clinical and operational commitment.

Canada

Canada's telemedicine deployment is shaped by provincial health authorities and public-payer structures. Rural access gaps, specialist availability, and provincial digital-health mandates sustain demand, even though procurement and reimbursement dynamics differ from the U.S. market.

Europe Telemedicine Market Analysis

The Europe telemedicine market generated USD 33.64 billion in 2025 and is forecast to grow at 9.7% CAGR (2026–2035). Growth is supported by national digital-health programs, cross-border data-policy development, and provider demand for scalable care pathways that can operate within rigorous privacy and governance frameworks.

Germany

Germany's digital-health reimbursement environment offers a comparatively structured route for certified solutions, making evidence, compliance, and integration readiness central to commercial success. The market remains influential in shaping broader European expectations for regulated digital care.

UK

The UK is expanding digital-first care through NHS-led primary-care and outpatient pathways. Integrated care structures create an opportunity to align provider capacity, patient access, and local population-health objectives through coordinated virtual-care deployment.

France

France is broadening teleconsultation use across reimbursed care pathways, with mental health and dermatology among the clinically suitable areas for virtual delivery.

Spain

Spain's telemedicine agenda emphasizes chronic-disease management and improved continuity between care settings, reinforcing the value of remote monitoring and coordinated follow-up.

Italy

Italy is developing hospital-to-home care models that make virtual care relevant to discharge planning, chronic-care coordination, and specialist continuity.

Poland

Poland combines evolving national regulatory frameworks with commercial platform activity, creating opportunities for providers that can adapt offerings to local reimbursement and clinical-practice requirements.

Belgium

Belgium's market is supported by established healthcare infrastructure and growing attention to secure, interoperable digital-care delivery.

Sweden

Sweden's eHealth strategy and digitally engaged population support telemedicine adoption, especially where remote care can strengthen access and efficiency within publicly coordinated services.

Switzerland

Switzerland's private-payer environment creates a distinct commercial pathway for telemedicine solutions, with value propositions centered on access, service quality, and care-navigation efficiency.

Asia Pacific Telemedicine Market Analysis

The Asia Pacific telemedicine market generated USD 29.76 billion in 2025 and is forecast to grow at 13.6% CAGR (2026–2035). Government-backed digital-health infrastructure, large underserved populations, and mobile-first consumer behavior are broadening access to virtual care across diverse clinical and reimbursement environments.

Japan

Japan's aging population and focus on chronic-disease management make remote monitoring and specialist access important use cases. Virtual care is increasingly relevant to supporting patients outside major care centers.

China

China's internet-hospital development and large digital-platform ecosystem are advancing patient-facing virtual-care models. Scale depends on balancing consumer accessibility with clinical integration and regulatory oversight.

India

India's digital-health infrastructure is creating a foundation for broader telemedicine delivery, particularly where specialist availability remains limited outside major metropolitan areas. Mobile accessibility and public-health interoperability are decisive adoption factors.

Australia

Australia's reimbursement support and longitudinal health-information infrastructure strengthen the operating case for virtual consultations, follow-up, and care coordination across geographically dispersed populations.

South Korea

South Korea's high connectivity and digital-platform capability support rapid adoption of clinically integrated virtual-care tools, particularly where AI-enabled decision support can be incorporated into specialist workflows.

Latin America Telemedicine Market Analysis

The Latin America telemedicine market generated USD 7.76 billion in 2025 and is forecast to grow at 13.3% CAGR (2026–2035). Unmet rural-access needs, mobile-first engagement, and public-sector digital-health programs are supporting demand, although infrastructure quality and payment capacity remain uneven across the region.

Brazil

Brazil is the region's anchor market, with public telehealth programs and urban private-platform activity creating complementary demand channels. Providers that can accommodate diverse connectivity conditions are better positioned to extend beyond affluent metropolitan users.

Mexico

Mexico's public health-system digital transformation is expanding the role of virtual care in access and care-navigation initiatives. The market's long-term potential rests on practical integration with public delivery infrastructure.

Middle East & Africa Telemedicine Market Analysis

The Middle East & Africa telemedicine market generated USD 7.76 billion in 2025 and is expected to reach USD 21.72 billion by 2035. The region combines investment-led digital-health development in Gulf markets with substantial unmet access needs across African healthcare systems, creating divergent adoption conditions and platform requirements.

Saudi Arabia

Saudi Arabia's digital-health investment agenda is supporting telemedicine integration across primary care, specialist referral, and chronic-condition management. National transformation initiatives make the Kingdom an important regional reference market for enterprise and government-led deployments.

South Africa

South Africa's comparatively developed digital infrastructure and evolving health-policy environment provide a potential entry point for regional platform expansion. The opportunity depends on solutions that can serve both well-resourced urban systems and underserved communities.

GMI Analyst View

We see the regional opportunity dividing between markets where reimbursement depth expands established use cases and markets where mobile infrastructure brings new patient populations into formal virtual-care channels. Winning across both settings requires different architectures, partnerships, and commercial models rather than a single global deployment playbook.

Telemedicine Market Share & Competitive Landscape

The telemedicine market share structure remains highly fragmented, with the top nine tracked companies accounting for approximately 5.3% of global revenue in 2025. Clinical delivery remains local: reimbursement rules, licensure, language, patient trust, and health-system integration limit the degree to which a single platform can replicate enterprise-software-style global consolidation.

Teladoc Health held 1.2% of the global telemedicine market in 2025. Its broad integrated-care portfolio spans chronic-condition management, mental health, and episodic care, positioning the company to compete for employer and payer relationships where demonstrated clinical outcomes and renewal performance are increasingly decisive.

Koninklijke Philips N.V. held 0.8% of the global telemedicine market in 2025. Its connected-care position is rooted in patient monitoring, clinical informatics, and hospital-based care environments, creating a differentiated route to remote-care deployment through installed clinical infrastructure.

GE HealthCare Technologies held 0.7% of the global telemedicine market in 2025. Its position is linked to patient monitoring and diagnostic connectivity, with hospital equipment relationships offering a channel for connected-care upgrades rather than a purely standalone-platform model.

American Well (Amwell) competes through enterprise-oriented, white-label telehealth deployment for health systems, payers, and public-sector clients. Its positioning reflects demand for virtual-care capabilities that can operate under a customer's own clinical identity.

Cisco Systems participates through secure collaboration and video infrastructure used in healthcare settings. Its role is primarily enabling rather than clinical, but the resilience and integration of that infrastructure can be material to enterprise telemedicine deployment.

Honeywell International addresses adjacent connected-care requirements through facility, safety, and monitoring capabilities. Its relevance is strongest where care delivery intersects with remote safety and healthcare-environment operations.

Oracle Corporation (Cerner) provides critical EHR and health-information infrastructure that supports the flow of clinical data between virtual and in-person encounters. Interoperability with the longitudinal patient record is a significant consideration for health systems evaluating telemedicine platforms.

AMC Health, AMD Global Telemedicine, Eagle Telemedicine, Health Catalyst, Masimo Corporation, McKesson Medical-Surgical, and SOC Telemed (Patient Square Capital) illustrate the diversity of specialized market participation, spanning remote patient monitoring, telemedicine equipment, acute-care specialist coverage, analytics, connected monitoring, supply infrastructure, and virtual hospital services.

HIPAA VIDEO.net, OBS Medical, RemetricHealth, Specialist Telemed, VCDoctor, and Veradigm LLC (Allscripts Healthcare Solutions) address more focused needs in compliant video infrastructure, patient safety, remote monitoring, specialty access, white-label deployment, and data-enabled clinical workflow integration. Competitive intensity will increasingly center on qualification barriers, clinical interoperability, security assurance, and the ability to demonstrate operational value to providers and payers.

Recent Industry Developments

Universal Health Services completed its acquisition of Talkspace in August 2026, bringing a virtual behavioral-health platform into a larger institutional behavioral-health delivery organization [5]. The transaction signals that virtual behavioral health is increasingly being treated as an integrated clinical channel rather than a separate consumer offering.

DocGo signed a definitive agreement to acquire Hicuity Health in August 2026, extending its connected-care strategy into virtual acute-care and specialist coverage for hospitals [6]. The proposed combination reflects growing interest in models that connect mobile, in-home, hospital-based, and remote-care services.

Need a specific section of this report?

Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.

Authors: Monali Tayade, Sampada Kulkarni
Telemedicine Market Scope
  • Telemedicine Market Size
  • Telemedicine Market Trends
  • Telemedicine Market Analysis
  • Telemedicine Market Share

Report Content

Chapter 1.   Research Methodology

1.1    Research approach

1.2    Quality Commitments

1.2.1    GMI AI policy & data integrity commitment

1.2.1.1    Source consistency protocol

1.3    Research Trail & Confidence Scoring

1.3.1    Research Trail Components

1.3.2    Scoring Components

1.4    Data Collection

1.4.1    Partial list of primary sources

1.5    Data mining sources

1.5.1    Paid sources

1.5.1.1    Sources, by region

1.6    Base estimates and calculations

1.6.1    Base year calculation

1.7    Forecast model

1.7.1    Quantified market impact analysis

1.7.1.1    Mathematical impact of growth parameters on forecast

1.8    Research transparency addendum

1.8.1    Source attribution framework

1.8.2    Quality assurance metrics

1.8.3    Our commitment to trust

Chapter 2.   Executive Summary

2.1    Industry 360° synopsis

2.2    Key market trends

2.2.1    Component trends

2.2.2    Specialty trends

2.2.3    End use trends

2.2.4    Regional trends

2.3    TAM analysis, 2027–2035

2.4    CXO perspectives: strategic imperatives

Chapter 3.   Industry Insights

3.1    Industry ecosystem analysis

3.1.1    Supplier Landscape

3.1.2    Profit Margin

3.1.3    Cost structure

3.1.4    Value addition at each stage

3.1.5    Factor affecting the value chain

3.1.6    Disruptions

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing prevalence of chronic diseases

3.2.1.2    Growing number of smartphone users

3.2.1.3    Technological advancements related to mobile phones and internet

3.2.1.4    Greater need for cost-saving in healthcare delivery

3.2.1.5    Favorable government initiatives across countries

3.2.2    Industry pitfalls and challenges

3.2.2.1    Security and privacy concerns

3.2.2.2    Limited digital literacy and technology access in low-income regions

3.2.3    Market opportunities

3.2.3.1    Expansion of telemedicine in emerging markets

3.2.3.2    Integration of AI and remote patient monitoring technologies

3.3    Growth potential analysis

3.4    Pricing Analysis (Driven by Primary Research)

3.4.1    Historical Price Trend Analysis

3.4.2    Pricing Strategy by Player Type (Premium / Value / Cost-plus)

3.5    Regulatory landscape

3.5.1    North America

3.5.2    Europe

3.5.3    Asia-Pacific

3.5.4    Latin America

3.5.5    Middle East and Africa

3.5.6    Reimbursement scenario

3.5.6.1    U.S.

3.5.6.2    Europe

3.6    Porter's analysis

3.7    PESTEL analysis

3.8    Trade Data Analysis (Based on Paid Database)

3.8.1    Import/Export Volume & Value Trends

3.8.2    Key Trade Corridors & Tariff Impact

3.9    Impact of AI & Generative AI on the Market (Driven by Primary Research)

3.9.1    AI-Driven Disruption of Existing Business Models

3.9.2    GenAI Use Cases & Adoption Roadmap by Segment

3.9.3    Risks, Limitations & Regulatory Considerations

3.10    Telemedicine modalities

3.11    Telemedicine initiatives

3.12    Telemedicine future trends

3.13    Analyst recommendations

3.14    Patent / IP Landscape

3.15    Medical Infrastructure Landscape

3.16    Epidemiology / Disease Burden

Chapter 4.   Competitive Landscape, 2025

4.1    Introduction

4.2    Company market share analysis

4.2.1    By Region

4.2.1.1    North America

4.2.1.2    Europe

4.2.1.3    Asia-Pacific

4.2.1.4    Latin America

4.2.1.5    Middle East and Africa

4.2.2    Market Concentration Analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Key developments

4.5.1    Mergers & acquisitions

4.5.2    Partnerships & collaborations

4.5.3    New product launches

4.5.4    Expansion plans and funding

4.6    Company tier benchmarking

4.6.1    Tier classification criteria & qualifying thresholds

4.6.2    Tier positioning matrix by revenue, geography & innovation

Chapter 5.   Market Estimates and Forecast, By Component, 2022 – 2035 ($ Mn)

5.1    Key trends

5.2    Hardware

5.3    Software

5.3.1    Cloud-based

5.3.2    On-premises

5.4    Services

5.4.1    Tele-consultation

5.4.2    Tele-monitoring

5.4.3    Tele-education/training

5.4.4    Other services

Chapter 6.   Market Estimates and Forecast, By Specialty, 2022 – 2035 ($ Mn)

6.1    Key trends

6.2    Pulmonary

6.3    Psychiatry

6.4    Cardiology

6.5    Endocrinology

6.6    Rheumatology

6.7    Gynecology

6.8    Gastroenterology

6.9    Oncology

6.10    Other specialties

Chapter 7.   Market Estimates and Forecast, By End Use, 2022 – 2035 ($ Mn)

7.1    Key trends

7.2    Healthcare providers

7.2.1    Hospitals and clinics

7.2.2    Long-term care centers

7.2.3    Other healthcare facilities

7.3    Payers

7.4    Patients

7.5    Other end users

Chapter 8.   Market Estimates and Forecast, By Region, 2022 – 2035 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Poland

8.3.7    Belgium

8.3.8    Sweden

8.3.9    Switzerland

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.6    Middle East and Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

Chapter 9.   Company Profiles

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below
country Flag
+1